Supplementary Figures
. Comparison of the survival rates of NACT + CCRT vs. NACT + IMRT with regard to (A) overall survival, (B) disease-free survival, (C) distant metastasis-free survival, and (D) loco-regional relapse-free survival in 4,109 patients. Figure S2 . Comparison of benefit of NACT + CCRT vs. NACT + IMRT with regard to (A) overall survival, (B) disease-free survival, (C) distant metastasis-free survival, and (D) loco-regional relapsefree survival in patients stratified by TNV groupings.
